Read this BuzzFeed news article on how scientists are beginning to talk about the possibility of curing cancer through immunotherapy. Features interviews with our very own professors and patients.
Nick Caunter, CEO of APH parking company, and his team of cyclists are half way through a 20k mile marathon cycle ride around the UK in a bid to raise £20k for the Centre for Cancer Immunology. See full story, including presentation of a cheque for £10k.
A symbolic milestone in the fight against cancer has been reached with the burial of a time capsule at the UK’s only dedicated Centre for Cancer Immunology. Read full coverage in the Daily Echo.
Dr Stephen Beers and his team have been awarded £200,000 by Bloodwise to investigate why some leukaemia patients don’t respond to a type of treatment. The grant will be used to find ways to reverse drug resistance in chronic lymphocytic leukaemia (CLL). Read the full story here in the Daily Echo.
Cancer Research UK have announced that our current facilities at Southampton General Hospital will be awarded £4m as part of a £16m UK initiative to help fight the most malignant cancers. The University of Southampton’s Professor Tim Elliott, Director of the Centre for Cancer Immunology, said: “We’re delighted to have been awarded this grant to further our understanding of how immunotherapies work.” Read full story in the Daily Echo.
Read The Sun’s current feature on cancer immunotherapy treatment and its success stories. One of the stories is about Julie Davies, a survivor of advanced follicular lymphoma, and one of our very own clinical trial patients. Here, she tells her own personal story of how an immunotherapy clinical trial put her into remission.
Watch this ITV Meridian News footage from World Cancer day. Kerry Swain talks to the brains behind this possible ‘cure’ and to the father of a three year old boy who is alive today thanks to our revolutionary immunotherapy treatment.
The Daily Echo’s Jenny Makin talks to one of our clinical trial patients, Patricia Marriott. Read how she is enjoying life 11 and a half years on, following immunotherapy treatment for advanced stage melanoma.
BioInvent International (STO:BINV) announces that it has gained access to novel technology for making highly efficacious immune stimulatory antibodies to combat cancer. This initiative continues BioInvent’s long standing research collaborations with the University of Southampton. Read full article from the Business Wire.
Can we ‘cure cancer”? Dr Edd James, Associate Professor in Cancer Immunology at the University of Southampton, explains what we mean by ‘curing cancer’ and how immunotherapy is providing exciting breakthroughs, in his inspiring article in The Conversation.